QMS Medical Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 Aug 2026 | Healthcare Equipment & Supplies | Market Cap: ₹287 Cr
Target to increase revenue from camps from INR13 crores in FY26 to approximately INR18-20 crores in FY27. QMS Medical Allied Services targets to increase service revenue from INR 50 crores in FY26 to around INR 100 crores by FY27, mainly driven by patient service programs and camps. - Revenue from camps is expected to grow from approx.
From QMS Medical's Q4 FY26 earnings-call transcript · updated 25 Aug 2026.
Price
₹149
Market Cap
₹287 Cr
P/E Ratio
26.7
Revenue Rank
Margin Rank
How does QMS Medical rank in Healthcare Equipment & Supplies?
Compare QMS Medical against every Healthcare Equipment & Supplies company this quarter on revenue, margins and earnings-call signals.
QMS Medical — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹37 Cr, net profit ₹3 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 2- →Target to increase revenue from camps from INR13 crores in FY26 to approximately INR18-20 crores in FY27.
- →Aim to double revenue from the services segment (camps and patient service programs) from around INR50 crores in FY26 to INR100 crores.
- →Overall revenue guidance for FY27 remains around INR216 crores.
- →Product segment expected to grow at 10-15% annually.
- →Services segment growth driven by new contracts, especially with GLP-1 drug patient engagement programs.
- →Plan to expand number of camps (32,380 conducted in FY26), though not necessarily doubling camp count next year.
- →Employee hiring targeted around 1,200 for patient service programs to support revenue growth.
- →EBITDA margin improvement expected with stabilized investments in people, technology, and infrastructure.
📈 Profitability & Margins
Rank 2- →QMS Medical Allied Services targets to increase service revenue from INR 50 crores in FY26 to around INR 100 crores by FY27, mainly driven by patient service programs and camps.
- →Revenue from camps is expected to grow from approx. INR 13 crores in FY26 to INR 18-20 crores in FY27.
- →The company aims to maintain EBITDA margins at around 18-19% in FY27, with service segment margins at approximately 25% EBITDA and product segment margins at 10-12% EBITDA.
- →Revenue growth guidance for FY27 remains INR 216 crores, in line with earlier guidance.
- →Profitability is expected to improve as investments in people, technology, and infrastructure (front-loaded in FY26) begin to yield returns.
- →Margins compressed in FY26 due to investments for new patient service programs; growth in FY27 expected to reflect a recovery.
- →EPS growth to follow overall revenue and margin growth, driven by scaling service revenues and contract-backed patient programs.
🏗️ Capital Expenditure Plans
Yes- →The company is making significant investments in its service segment, focusing on people, infrastructure, and technology to double service revenue in FY26-27.
- →Investments include hiring new employees (targeting 1,200 hires, with 800-850 already onboarded as of May) for patient service programs.
- →Capital is being allocated to software development and data compliance systems to meet DPDP Act requirements and enhance service capabilities.
- →These investments involve intangible assets such as people and custom software, which are expensed currently rather than capitalized.
- →Equipment for camp employees is a fixed cost (INR 20-25 lakh worth per employee) to support the expansive network covering 5,000 pin codes.
- →No explicit mention of large-scale traditional capex or strategic acquisitions; emphasis is on building scalable business infrastructure and service capabilities.
💰 Fundraising & Capital Structure
No information📋 Order Book & Pipeline
Yes- →The company experienced order delays in Q3 and Q4 FY26, primarily on the product segment, due to supply chain and shipping disruptions.
- →Some March orders were pushed into April and May.
- →Management expects smoother order flow and positive growth in Q1 and Q2 FY27 compared to the previous year.
- →No specific quantitative order book or pending orders value was disclosed in the transcript.
- →Confidence expressed in improving the supply-side challenges moving forward.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were QMS Medical Q4 FY26 results?
Target to increase revenue from camps from INR13 crores in FY26 to approximately INR18-20 crores in FY27. QMS Medical Allied Services targets to increase service revenue from INR 50 crores in FY26 to around INR 100 crores by FY27, mainly driven by patient service programs and camps. - Revenue from camps is expected to grow from approx.
What is QMS Medical share price analysis?
QMS Medical currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 26.7 with a market cap of ₹287 Cr. Investors should review the full earnings analysis for detailed insights.
Is QMS Medical planning capital expenditure?
The company is making significant investments in its service segment, focusing on people, infrastructure, and technology to double service revenue in FY26-27.
Keep QMS Medical on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.